Home › Procedures › MRI Abdomen › UnitedHealthcare
📋

UnitedHealthcare — MRI Abdomen

This page shows prior authorization criteria extracted from UnitedHealthcare's published imaging guidelines. 174 matching coverage rules found for this procedure.

Coverage Rules from UnitedHealthcare Policy

Abdominal Pain

Indication Code: AB-2.2

Abdominal Wall Mass

Indication Code: PEDAB-13.1

Abdominal Wall Mass

Indication Code: AB-13.1

Abnormal Liver Chemistries

Indication Code: AB-30.1

Acute Pancreatitis

Indication Code: PEDAB-34.1

Acute Pancreatitis

Indication Code: AB-33.1

Adrenal Gland Metastases

Indication Code: ONC-31.4

Adrenal Hormone Excess/Symptomatic Adrenal Lesions

Indication Code: AB-16.2

Adrenal Lesions

Indication Code: PEDAB-17

Adrenal Lesions

Indication Code: PEDAB-17

Adrenal Tumors – Initial Work-up/Staging

Indication Code: ONC-15.10

Adrenal Tumors – Restaging/Recurrence

Indication Code: ONC-15.11

Adrenal Tumors – Surveillance

Indication Code: ONC-15.12

Adrenocortical Carcinoma

Indication Code: ONC-15.13

Amenorrhea

Indication Code: PEDPV-4.1

Anal Carcinoma – Restaging/Recurrence

Indication Code: ONC-24.3

Anal Carcinoma – Surveillance

Indication Code: ONC-24.4

Asymptomatic Adrenal Cortical Lesions

Indication Code: AB-16.1

Asymptomatic Elevation of Pancreatic Enzymes

Indication Code: AB-33.4

Asymptomatic Hematuria

Indication Code: AB-39.2

Bilateral Wilms Tumor (BWT)

Indication Code: PEDONC-7.3

Biliary Disease

Indication Code: PEDAB-16.2

Bowel Obstruction

Indication Code: AB-20.1

Bowel Obstruction

Indication Code: PEDAB-28.1

Bronchopulmonary or Thymic Carcinoid – Initial Staging

Indication Code: ONC-15.6

Bronchopulmonary or Thymic Carcinoid – Restaging/Recurrence

Indication Code: ONC-15.7

Bronchopulmonary or Thymic Carcinoid – Surveillance

Indication Code: ONC-15.8

Cancers of External Genitalia – Initial Work-Up/Staging

Indication Code: ONC-24.6

Cancers of External Genitalia – Restaging/Recurrence

Indication Code: ONC-24.7

Cardiac Imaging in Transplants

Indication Code: CD-16

Celiac Disease

Indication Code: AB-24.1

CHF – Imaging

Indication Code: CD-9.1

Chronic Diarrhea (More than 30 Days)

Indication Code: AB-21.2

Chronic Liver Disease, Cirrhosis and Screening for HCC

Indication Code: AB-26.1

Chronic Pancreatitis

Indication Code: PEDAB-34.2

Chronic Pancreatitis

Indication Code: AB-33.2

Classical Hodgkin Lymphoma

Indication Code: ONC-28.2

Clear Cell Sarcoma of the Kidney (CCSK)

Indication Code: PEDONC-7.5

Colorectal Cancer – Initial Work-up/Staging

Indication Code: ONC-16.2

Colorectal Cancer – Restaging/Recurrence

Indication Code: ONC-16.3

Colorectal Cancer – Surveillance/Follow-up

Indication Code: ONC-16.4

Congenital Mesoblastic Nephroma (CMN)

Indication Code: PEDONC-7.7

Exocrine Pancreatic Insufficiency

Indication Code: AB-33.3

Extrathoracic Small Cell and Large Cell Neuroendocrine Tumors

Indication Code: ONC-31.8

Familial Adenomatous Polyposis (FAP) and Related Conditions

Indication Code: PEDONC-2.7

Fatty Liver (Metabolic Associated Steatotic Liver Disease (MASLD), formerly known as NAFLD)

Indication Code: AB-29.2

Fistulae

Indication Code: AB-48

Fistulae

Indication Code: AB-48

Flank Pain, Renal Stone

Indication Code: PEDAB-4

Flank Pain, Renal Stone

Indication Code: PEDAB-4

Gallbladder

Indication Code: AB-28.1

Gallbladder and Biliary Tumors – Initial Work-up/Staging

Indication Code: ONC-14.6

Gallbladder and Biliary Tumors – Restaging/Recurrence

Indication Code: ONC-14.7

Gallbladder and Biliary Tumors – Surveillance/Follow-up

Indication Code: ONC-14.8

Gastric Cancer – Restaging/Recurrence

Indication Code: ONC-14.10

Gastric Cancer – Surveillance/Follow-up

Indication Code: ONC-14.11

Gastrointestinal Stromal Tumor (GIST)

Indication Code: ONC-12.5

Gastrointestinal/Pancreatic Neuroendocrine Cancers – Initial Work-up/Staging

Indication Code: ONC-15.3

Gastrointestinal/Pancreatic Neuroendocrine Cancers – Restaging/Recurrence

Indication Code: ONC-15.4

Gastrointestinal/Pancreatic Neuroendocrine Cancers – Surveillance

Indication Code: ONC-15.5

Gastrointestinal/Pancreatic Neuroendocrine Cancers – Suspected/Diagnosis

Indication Code: ONC-15.2

Gaucher Disease (Storage Disorders)

Indication Code: PN-8.6

GI Bleeding

Indication Code: AB-22.1

Hemophagocytic Lymphohistiocytosis (HLH)

Indication Code: PEDONC-18.3

Hepatic Arteries and Veins

Indication Code: AB-43.1

Hepatoblastoma

Indication Code: PEDONC-11.2

Hepatocellular Carcinoma (HCC) – Initial Work-up/Staging

Indication Code: ONC-14.3

Hepatocellular Carcinoma (HCC) – Restaging/Recurrence

Indication Code: ONC-14.4

Hepatocellular Carcinoma (HCC) – Surveillance/Follow-up

Indication Code: ONC-14.5

Hereditary (Primary) Hemochromatosis (HH) and Other Iron Storage Diseases

Indication Code: AB-11.2

Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)

Indication Code: PEDONC-2.16

Hereditary Paraganglioma-Pheochromocytoma (HPP) Syndromes

Indication Code: PEDONC-2.13

Histiocytic Disorders – General Considerations

Indication Code: PEDONC-18.1

Hydronephrosis

Indication Code: PEDAB-20

Hydronephrosis

Indication Code: PEDAB-20

Incidental Pancreatic Mass or Suspected Metastatic Disease to Pancreas

Indication Code: AB-31.2

Indeterminate Intra-Abdominal Mass

Indication Code: AB-13.2

Indeterminate Renal Lesion

Indication Code: PEDAB-19

Indeterminate Renal Lesion

Indication Code: PEDAB-19

Indeterminate Renal Lesion

Indication Code: AB-35.1

Indications for Cardiac MRI

Indication Code: PEDCD-9.3

Inflammatory Bowel Disease, Crohn Disease, or Ulcerative Colitis

Indication Code: PEDAB-9

Inflammatory Bowel Disease, Crohn Disease, or Ulcerative Colitis

Indication Code: PEDAB-9

Kidney Transplant, Pre-Transplant Imaging Studies

Indication Code: AB-42.5

Known IBD

Indication Code: AB-23.2

Langerhans Cell Histiocytosis (LCH)

Indication Code: PEDONC-18.2

Liver Elastography

Indication Code: AB-45

Liver Elastography

Indication Code: AB-45

Liver Lesion Characterization

Indication Code: PEDAB-15

Liver Lesion Characterization

Indication Code: PEDAB-15

Liver Lesion Characterization

Indication Code: AB-29.1

Liver Metastases and Liver-Directed Therapies

Indication Code: ONC-31.2

Liver Transplant, Living Donor Pre-Transplant Imaging (Donor Imaging)

Indication Code: AB-42.2

Liver Transplant, Post-Transplant Imaging

Indication Code: AB-42.3

Liver Transplant, Pre-Transplant

Indication Code: AB-42.1

Lower Urinary Tract Infection

Indication Code: AB-40.2

Lumbar and Lumbosacral Plexus

Indication Code: PN-5.1

LUMBAR Syndrome

Indication Code: PEDPVD-5.4

Malignant Rhabdoid Tumor of the Kidney (MRT) and Other Extracranial Sites

Indication Code: PEDONC-7.6

Monitoring After Fontan Procedure

Indication Code: AB-26.4

MR Enterography and Enteroclysis Coding Notes

Indication Code: AB-1.4

MR Imaging

Indication Code: AB-1.3

MRCP

Indication Code: AB-27.1

Multiple Endocrine Neoplasias (MEN)

Indication Code: PEDONC-2.8

Neuroblastoma – Initial Staging

Indication Code: PEDONC-6.3

Neuroblastoma – Surveillance Imaging (Risk Group Dependent)

Indication Code: PEDONC-6.5

Neuroblastoma – Treatment Response Imaging (Risk Group Dependent)

Indication Code: PEDONC-6.4

Neuromuscular Junction Disorders

Indication Code: PN-8.4

Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)

Indication Code: PEDONC-8.3

Ocular Melanoma

Indication Code: ONC-5.9

Other Renal Cell Cancer Predisposition Syndromes

Indication Code: PEDONC-2.17

Ovarian Cancer – Initial Work-Up/Staging

Indication Code: ONC-21.3

Ovarian Cancer – Restaging/Recurrence

Indication Code: ONC-21.4

Ovarian Cancer – Surveillance

Indication Code: ONC-21.5

Ovarian Cancer – Suspected/Diagnosis

Indication Code: ONC-21.2

Pancreatic Cancer – Initial Work-up/Staging

Indication Code: ONC-13.3

Pancreatic Cancer – Restaging/Recurrence

Indication Code: ONC-13.4

Pancreatic Cancer – Screening Studies for Pancreatic Cancer

Indication Code: ONC-13.1

Pancreatic Cancer – Surveillance/Follow-up

Indication Code: ONC-13.5

Pancreatic Cancer – Suspected/Diagnosis

Indication Code: ONC-13.2

Pancreatic Cystic Lesions

Indication Code: AB-31.1

Paraneoplastic Syndromes

Indication Code: ONC-30.3

Pediatric Abdomen Imaging Modality General Considerations

Indication Code: PEDAB-1.3

Pediatric ACC – Imaging

Indication Code: PEDONC-14.2

Pediatric Aggressive Mature B-Cell Non-Hodgkin Lymphomas (NHL)

Indication Code: PEDONC-5.3

Pediatric Germ Cell Tumors

Indication Code: PEDONC-10

Pediatric Germ Cell Tumors

Indication Code: PEDONC-10

Pediatric Hepatocellular Carcinoma (HCC)

Indication Code: PEDONC-11.3

Pediatric Hodgkin Lymphoma (HL)

Indication Code: PEDONC-5.2

Pediatric Liver Failure and Cirrhosis

Indication Code: PEDAB-16.1

Pediatric Pancreatic Carcinoma

Indication Code: PEDONC-11.4

Pediatric Renal Cell Carcinoma (RCC)

Indication Code: PEDONC-7.4

Polycystic Kidney Disease

Indication Code: PEDAB-21

Polycystic Kidney Disease

Indication Code: PEDAB-21

Polycystic Kidney Disease

Indication Code: AB-38.1

Polycystic Liver Disease

Indication Code: AB-29.3

Portal Hypertension

Indication Code: AB-26.3

Post-Transplant Imaging

Indication Code: PEDONC-20.2

Postoperative Pain within 60 Days Following Abdominal Surgery

Indication Code: PEDAB-11

Postoperative Pain within 60 Days Following Abdominal Surgery

Indication Code: PEDAB-11

Pre-operative Assessment for Robotic Kidney Surgery

Indication Code: AB-35.2

Pyelonephritis

Indication Code: AB-40.1

Renal Cell Cancer (RCC) – Initial Work-up/Staging

Indication Code: ONC-17.2

Renal Cell Cancer (RCC) – Surveillance

Indication Code: ONC-17.4

Retinoblastoma – Imaging

Indication Code: PEDONC-12.2

Retroperitoneal Fibrosis

Indication Code: AB-47.0

Right Lower Quadrant Pain

Indication Code: PEDAB-3

Right Lower Quadrant Pain

Indication Code: PEDAB-3

Right Upper Quadrant and Epigastric Pain

Indication Code: AB-2.3

Right Upper Quadrant Pain

Indication Code: PEDAB-8

Right Upper Quadrant Pain

Indication Code: PEDAB-8

Small Bowel Bleeding Suspected

Indication Code: AB-22.2

Small Bowel Cancer – Initial Work-up/Staging

Indication Code: ONC-16.5

Small Bowel Cancer – Restaging/Recurrence

Indication Code: ONC-16.6

Soft Tissue Sarcomas – Initial Work-up/Staging

Indication Code: ONC-12.2

Spleen

Indication Code: AB-34.1

Suspected IBD (Crohn’s Disease or Ulcerative Colitis)

Indication Code: AB-23.1

Suspected Renal/Ureteral Stone(s)

Indication Code: AB-4.1

Testicular, Ovarian and Extragonadal Germ Cell Tumors – General Considerations

Indication Code: ONC-20.0

Testicular, Ovarian and Extragonadal Germ Cell Tumors – Initial Work-Up/Staging

Indication Code: ONC-20.1

Testicular, Ovarian and Extragonadal Germ Cell Tumors – Restaging/Recurrence

Indication Code: ONC-20.2

Testicular, Ovarian and Extragonadal Germ Cell Tumors – Surveillance

Indication Code: ONC-20.3

Thyroid Cancer – Initial Work-up/Staging

Indication Code: ONC-6.2

Thyroid Cancer – Restaging/Recurrence

Indication Code: ONC-6.3

Transfusion-Associated (Secondary) Hemochromatosis

Indication Code: PEDAB-18.2

Transitional Cell Cancer – Initial Work-up/Staging

Indication Code: ONC-18.2

Transitional Cell Cancer – Surveillance/Follow-up

Indication Code: ONC-18.4

Tuberous Sclerosis Complex (TSC)

Indication Code: PEDONC-2.9

Undescended Testis

Indication Code: PEDPV-11.1

Unexplained Weight Loss

Indication Code: ONC-30.2

Unilateral Wilms Tumor (UWT)

Indication Code: PEDONC-7.2

Upper Urinary Tract

Indication Code: PEDAB-5.1

Uterine Anomalies

Indication Code: PV-14.1

Von Hippel-Lindau Syndrome (VHL)

Indication Code: PEDONC-2.10

How to Submit a Prior Authorization Request

Submit via: UnitedHealthcare Provider Portal (provider.uhc.com) or OptumRx at 1-888-936-7246

📄 Required Documentation Checklist

  • Patient demographics and insurance information
  • Ordering provider NPI and contact information
  • Specific clinical indication with ICD-10 diagnosis code(s)
  • Relevant clinical history and physical exam findings
  • Results of prior conservative treatment (if applicable)
  • Prior imaging results relevant to the indication
  • Supporting lab or diagnostic results where applicable

⏱ Turnaround Times

Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.

📣 Appeal Window

Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.

⚠ Common Denial Reasons

  • Insufficient clinical documentation to establish medical necessity
  • Clinical criteria not met per payer guidelines
  • Lack of documented prior conservative treatment
  • Missing required prior imaging as step therapy
  • Incorrect or unsupported ICD-10 diagnosis code pairing
  • Request submitted outside of authorization timeframe

⚠ MRI uses no ionizing radiation, which is an important clinical consideration when choosing between MRI and CT.

Clinical Approval Criteria

✓ Generally Approved When:

  • Reference the prior imaging that identified the finding being evaluated
  • For HCC surveillance: document cirrhosis diagnosis and surveillance protocol
  • For adrenal mass: document size and CT characteristics that necessitate MRI
← Back to MRI Abdomen overview Search Coverage Database →
Disclaimer: Coverage criteria shown on this page are sourced from publicly available payer guidelines and are provided for informational and educational purposes only. Prior authorization requirements change frequently. Always verify current criteria directly with the payer or their delegated utilization management company before submitting an authorization request. This page does not constitute medical or legal advice.